首页>
外国专利>
Injectable formulation of paclitaxel for cad treatment
Injectable formulation of paclitaxel for cad treatment
展开▼
机译:用于cad治疗的紫杉醇注射剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
A liquid formulation of a therapeutic agent comprising: a taxane in a pharmaceutically effective dosage; and one or more pharmaceutically acceptable solubility enhancers is disclosed. The liquid formulation may further comprise stabilizers. The taxane in solution may be in the range 0.05 mg/ml to 5 mg/ml. An injectable formulation of a therapeutic agent comprising: a taxane in a pharmaceutically effective dosage; and one or more pharmaceutically acceptable solubility enhancers is also described. The concentration of the taxane in suspension may be in the range from about 1 mg/ml to about 15 mg/ml.
展开▼